Galenusrx

Founded in 2023 by a team of internationally recognized healthcare leaders, GalenusRx is revolutionizing medication safety with the power of precision. The company’s proprietary platform, APPRAISE, analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to provide a unique and comprehensive risk assessment, individualized down to the DNA. Through the Lifesaving InsightsTM consulting service, Precision Clinical Pharmacists deliver tailored recommendations for safer, more effective drug regimens. Together, these solutions directly address polypharmacy and the potential for adverse drug events — a leading cause of death in the United States. GalenusRx’s deep data analysis also enhances the quality, safety, and efficiency of virtual clinical trials, allowing for biosimulations based on real patient data that don’t expose patients to risk. The benefits span from consumers to healthcare providers, insurers, and pharmaceutical companies, with GalenusRx’s technology leading the way toward better health outcomes and lower medical costs.